Mary Fisher, Chief Operating Officer at ACORDA THERAPEUTICS INC (ACOR), sold 7,500 shares at $17.63 ($132K) on 2007-02-01, disclosed to the SEC on 2007-02-02.
Scheduled sale ($132k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.45 | 500 | $9K | 6.6% |
| 2 | $17.52 | 1,000 | $18K | 13.3% |
| 3 | $17.53 | 844 | $15K | 11.2% |
| 4 | $17.54 | 156 | $3K | 2.1% |
| 5 | $17.55 | 500 | $9K | 6.6% |
| 6 | $17.56 | 1,000 |
| $18K |
| 13.3% |
| 7 | $17.60 | 400 | $7K | 5.3% |
| 8 | $17.61 | 200 | $4K | 2.7% |
| 9 | $17.62 | 100 | $2K | 1.3% |
| 10 | $17.63 | 200 | $4K | 2.7% |
| 11 | $17.64 | 300 | $5K | 4.0% |
| 12 | $17.66 | 700 | $12K | 9.4% |
| 13 | $17.68 | 600 | $11K | 8.0% |
| 14 | $17.76 | 500 | $9K | 6.7% |
| 15 | $17.78 | 500 | $9K | 6.7% |
| Total | $17.60 avg | 7,500 | $132K | 100% |
| Filing → |
| OVAS | BUY | 2015-09-11 | $101K | — | Filing → |
| ZLTQ | SELL | 2015-01-27 | $1.7M | — | Filing → |
| ACOR | SELL | 2007-07-05 | $133K | — | Filing → |